Svar Life Science

April 20, 2021

CASE STUDY: How to Design Potency Assays for Gene Therapy Projects

Learn more about the process at Svar of designing, constructing, producing and validating a fit-for purpose potency assay for use in batch release of an AAV based gene therapy drug.

In the Select Science editorial special feature "Advances in Drug Discovery", we describe the process of developing an advanced potency assay for an advanced product, like the reporter-gene assay – from the initial contact with the client through development and validation to manufacturing of the finished product.

April 20, 2021

CASE STUDY: How to Design Potency Assays for Gene Therapy Projects

Learn more about the process at Svar of designing, constructing, producing and validating a fit-for purpose potency assay for use in batch release of an AAV based gene therapy drug.

In the Select Science editorial special feature "Advances in Drug Discovery", we describe the process of developing an advanced potency assay for an advanced product, like the reporter-gene assay – from the initial contact with the client through development and validation to manufacturing of the finished product.

Since gene therapy offers hope for the hundreds of millions of people that live with genetic diseases worldwide, it is important to find tools and analytical solutions that can support this new and exciting field, and that always have the patients’ safety as a top priority.

Svar Life Science has extensive experience in developing iLite reporter-gene assays and can create cell-based assays for almost any target. Using this knowledge, we help pharmaceutical companies create safe and effective treatments and help advance drug discovery.

Quick links:

Would you like to book one of our experts for a free consultation?

Our scientific experts are here and ready to help - a great opportunity to discuss your specific projects!

Book a free iLite consultation

 


Complete the form to receive the Case Study via email!